🔗 Share this article

Given that America undertakes historic revisions to its immunization recommendations, a particular individual has emerged somewhat surprisingly: Tracy Beth Høeg, an American of Danish descent sports medicine doctor and epidemiologist who initially gained attention by expressing skepticism about Covid vaccinations in the pandemic and has zeroed in on possible deaths after Covid immunization in her short position at the FDA.

Planned Overhauls to Pediatric Immunization Schedule

Agency leaders planned to reveal sweeping changes to the pediatric vaccination calendar recently, synchronizing the US with Denmark’s vaccine program, sources say – a major change that would put the US out of alignment with much of the global community with little proof for benefit. The planned update has been pushed back until the next year.

Instead of Vinay Prasad, Høeg is listed to present at the meeting. She was recently named interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to lead the division this calendar year.

Consolidating Power at the Regulatory Body

Høeg's temporary position may indicate a closer partnership between the pharmaceutical and vaccine divisions as Høeg and Dr. Prasad solidify control at the agency – and it signals a greater focus upon dismantling previously authorized vaccines at the FDA.

The new acting director has repeatedly called for discontinuing some pediatric shot schedules in the US so as to align more in line with Denmark, a nation with nationalized medicine and a citizenry about the population of Wisconsin’s.

In her initial public appearances, she has continued to focus on immunizations – traditionally the domain of Prasad, chief of the FDA’s vaccine center – rather than pharmaceutical oversight.

Concerns Over Expertise

Dr. Høeg has no obvious experience in pharmaceutical research, oversight or management, which has been customary for past directors of the biologics center. She has worked at the FDA as a key advisor to the FDA chief and the vaccine center since March.

“She doesn’t seem to have any of the qualifications” for running the pharmaceutical oversight division, remarked Dr. Jonathan Howard. “She’s never run a randomized controlled trial. She is not versed in running a sizeable institution. She has no expertise in pharmaceutical oversight.”

Past commissioners of the center would “understand laws and regulations and the science of medication creation”, commented Janet Woodcock. “Frankly, she lacks the sort of resume that previous people who headed CBER have had.”

CDER has an immense portfolio at the agency, Woodcock emphasized.

“The public just pays attention on the novel medication approvals, but the generic drug division authorizes a multitude of off-brand pharmaceuticals. There’s a biosimilars division, non-prescription drug unit and more, and every single one need to be supervised,” Dr. Woodcock explained. “The responsibility you neglect, that is the part that I always told people is going to bite you.”

Furthermore, a significant management aspect to the job, which oversees in excess of 5,000 staff members. “It’s a enormous management job, if you execute it properly,” the former official added.

Response and Contentious Programs

In response to concerns about Dr. Høeg's credentials and whether this assignment represents more teamwork among regulatory chiefs on vaccines, a spokesperson said that the “questions stem from incorrect assumptions”.

“This background matches the responsibilities of her position,” the spokesperson said, pointing to the period Dr. Høeg spent guiding the FDA commissioner on “drug safety and approval science, including computational safety modeling and shot safety tracking”.

As the temporary head, Høeg takes over the agency head's new fast-track approval initiative, a contentious expedited drug-approval program that allegedly concerned her preceding directors. “How are these therapies being picked for this expedited pathway? Who is making the calls?” Dr. Howard said. “There is a lot of lack of transparency going on at the FDA right now.”

In general, he remarked, “the agency looks to be trending towards less stringent regulations of most medications, with the exception of immunizations.”

Public History on Immunizations

Regarding vaccines, Høeg has a more established, if problematic, past, some experts have noted. She released a analysis using unverified crowd-sourced reports to estimate the rate of heart inflammation after Covid vaccination. She consulted for the Florida chief medical officer Joseph Ladapo, who was said to have changed statistics to suggest COVID-19 vaccinations are pose a greater threat than they are.

Included in her “policy goals” for the new federal leadership featured altering guidelines for recently developed shots and ending “optional” immunizations, she stated post-election on a podcast. At the agency, Høeg has reportedly floated the idea of barring young men from getting Covid vaccines.

“She is an thorough dogmatist who begins with her beliefs and tailors the evidence to fit the data in a highly misleading, dishonest fashion,” Dr. Howard stated.

Taking Control and a “Revenge Tour”

Høeg aligned with fellow skeptics, {like|